Brain zaps may tame sensory overload in kids with autism
NCT ID NCT07182331
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests whether a non-invasive brain stimulation technique called cTBS can improve how children with autism (ages 6-12) combine what they see and hear. Forty children will receive either real or sham stimulation over 10 sessions. Researchers will use brain scans, genetic tests, and sensory tasks to see if the treatment works and who benefits most.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
continuous theta-burst stimulation (cTBS) - a type of non-invasive brain stimulation
What this could lead to
If it works, this could point toward a non-drug treatment to help children with autism process sights and sounds more easily, potentially reducing sensory overload.
What could go wrong
This is a small, early-stage study with only 40 children. The treatment may not work better than sham stimulation, and results may not apply to all children with autism. Brain stimulation can sometimes cause discomfort or headache.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER (ASD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Neurolab Plus
Almaty, 050000, Kazakhstan
-
Non-profit joint-stock company "Al-Farabi Kazakh National University"
Almaty, 050040, Kazakhstan